Features
Get A Demo
Plans
Sign Up
Login
All Federal Contract IDV Awards
Help
Basic Ordering Agreement N6833521G0017
Award Date
4/22/21
Last Date to Order
2/24/26
Overview
AI Insights
Buyer Personas
Industry Personas
Buyer Personas In this Market
98
Activity
3
Contract IDVs
Contract Awards
1
Transactions
3
Price Lists
Opportunity Stack
Federal Agency
Naval Air Warfare Center
Awardee
Autonomous Therapeutics Inc.
Ultimate Awardee
Not listed
NAICS Category
541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
PSC Category
AC13 - National Defense R&D Services; Department Of Defense - Military; Experimental Development
Federal Contract Vehicle
Not listed
Pricing Type
Order Dependent (IDV only)
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
N6833521G0017
Basic Ordering Agreement
1
Federal Contract Awards
Description
Update #1
BASIC ORDERING AGREEMENT IN SUPPORT OF OSD TOPIC X20R-DCS01.
Posted 4/22/21, 12:00 AM
Mod #
Description
Reason For Modification
Federal Obligation
(Click to sort descending)
Date
(Click to sort ascending)
P00002
THE PURPOSE OF THIS MODIFICATION IS TO UPDATE DFARS CLAUSE 252.245-7002. ALL OTHER TERMS AND CONDITIONS REMAIN UNCHANGED.
Other Administrative Action
$0
8/4/21
P00001
THE PURPOSE OF THIS MODIFICATION IS TO UPDATE THE ADMINISTRATION, PAYMENT, AND DCAA OFFICE INFORMATION. ALL OTHER TERMS AND CONDITIONS REMAIN UNCHANGED.
Other Administrative Action
$0
6/4/21
Not listed
BASIC ORDERING AGREEMENT IN SUPPORT OF OSD TOPIC X20R-DCS01.
Not listed
$0
4/22/21
Name
Description
Awardee
Potential Value
(Click to sort descending)
Award Date
(Click to sort descending)
Completion Date
(Click to sort descending)
Updated At
(Click to sort descending)
Delivery Order N6833521G0017-N6833521F0315
The Department of the Navy, Naval Air Systems Command, Naval Air Warfare Center awarded a Small Business Innovation Research Phase II Research and Development Delivery Order contract valued at approximately one million dollars to Autonomous Therapeutics Inc., located in Rockville, Maryland. The contract period of performance extends from May 2021 through September 2023. This cost-plus-fixed-fee contract supports the SBIR program's Phase II objective of continuing research and development on topics aligned with the Navy's priorities. As a total small business set-aside, this award aims to foster innovation through small business partnerships. Autonomous Therapeutics will conduct R&D at its Rockville facility to advance naval aviation technology goals over the next two years.
Autonomous Therapeutics Inc.
$1.0m
5/7/21
9/30/23
7/30/21